Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Hermes Pharma Completes First FDA Inspection | Contract Pharma
Breaking News

Hermes Pharma Completes First FDA Inspection

Wolfratshausen facility supports dosage forms for U.S. distribution

Hermes Pharma has successfully completed its first FDA inspection of its production facility in Wolfratshausen, Germany. The inspection covered reviews of general systems, including training, equipment calibration and qualification, standard operating procedures, protocols and methods. It also appraised Hermes Pharma’s Hazard Analysis and Critical Control Point (HACCP) system.


The Wolfratshausen facility along with a production facility in Wolfsberg, Austria, allows Hermes to support global customers looking to license user-friendly dosage forms for distribution and sale in the U.S. The two plants are equipped with similar production lines to help ensure supply without interruptions. Dosage forms include instant drinks, orally disintegrating granules, lozenges, effervescent and chewable tablets.


“As a developer of pharmaceuticals and food supplements we work on a global basis, and understand and value compliance – to assure quality and adherence for our customers,” said Dr. Thomas Hein, director of sales and business development, Hermes Pharma. “This represents an important milestone for Hermes Pharma as the company steadily increases its manufacturing support for pharmaceutical companies around the world, especially those that seek access to the US marketplace or are already operating in the country.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters